loader2
Login Open ICICI 3-in-1 Account
Text Size
Text to Speech
Color Contrast
Pause Animations

Mar 02, 2026

loader2

Open ICICI 3-in-1 Account

Manage your Savings, Demat and Trading Account conveniently at one place

What is Nifty 200?

Company Name PE Mcap/Sales P/BV EV/EBIDTA D/E ROCE ROE
Abbott India Ltd 36.94 8.73 14.06 36.36 0.04 44.95 35.66
Cipla Ltd 24.01 3.95 3.31 15.56 0.02 23.15 18.28
J B Chemicals & Pharmaceuticals Ltd 43.73 8.41 8.66 32.74 0.06 26.42 20.75
Dr Reddys Laboratories Ltd 19.45 3.29 2.98 13.20 0.11 23.05 18.53
Lupin Ltd 22.53 4.63 5.36 20.28 0.27 20.88 21.00
Torrent Pharmaceuticals Ltd 64.61 12.75 17.36 45.52 0.50 25.84 26.46
Ipca Laboratories Ltd 41.29 4.35 5.22 26.46 0.21 17.12 13.61
Sun Pharmaceutical Industries Ltd 38.07 7.93 5.36 27.00 0.04 19.52 16.16
Aurobindo Pharma Ltd 20.36 2.24 2.02 11.68 0.24 14.16 11.15
Wockhardt Ltd -2,195.32 7.34 4.85 78.27 0.57 3.87 -1.48
Ajanta Pharma Ltd 36.88 8.05 8.67 29.18 0.01 31.98 25.02
Gland Pharma Ltd 35.45 5.35 3.14 20.13 0.00 15.83 11.62
Biocon Ltd 100.45 4.14 1.67 22.71 0.84 6.86 6.90
Alkem Laboratories Ltd 27.83 5.20 5.05 27.52 0.13 20.03 19.88
Glenmark Pharmaceuticals Ltd 56.64 4.53 6.29 34.02 0.22 18.48 15.79
Zydus Lifesciences Ltd 18.47 3.99 3.67 12.78 0.09 24.56 21.08
Divis Laboratories Ltd 68.67 18.19 11.04 56.47 0.00 20.42 15.35
Mankind Pharma Ltd 51.46 7.60 6.07 34.46 0.37 16.04 14.83
Laurus Labs Ltd 69.03 10.45 12.09 59.14 0.62 8.80 7.36
Piramal Pharma Ltd -126.95 2.27 2.57 21.10 0.60 6.43 1.14

Other Indices

INDEX NAME MARKET VALUE 52W HIGH 52W LOW
Nifty Next 50 68650.25
(-1.5215%)
70833.65 56192.45
Nifty Bank 59839.65
(-1.1389%)
61764.85 47702.90
Nifty 50 24865.70
(-1.2429%)
26373.20 21743.65
Nifty 100 25563.50
(-1.2899%)
26975.15 22177.35
BSE SmallCap 46825.31
(0.0%)
55792.26 41013.68
BSE Sensex 80238.85
(-1.2897%)
86159.02 71425.01
BSE MidCap 44246.27
(0.0%)
47764.30 37203.21
BSE 100 26100.16
(-1.3094%)
27621.72 22539.11

Nifty Pharma

The NIFTY Pharma Index reflects the behaviour and performance of the pharmaceutical sector in India. The index has a maximum of 20 stocks since the last amendment effective from 30th September 2021. The NIFTY Pharma stocks are calculated using the free-float market capitalization method and can be used for benchmarking fund portfolios, among other utilization for investors. The index was launched in July 2005; the base date being 1st January 2001 with a base value of 1000. Index is re-balanced on semi-annual basis. The cut-off date is January 31 and July 31 of each year. When rebalancing, the weightage of each stock in the index is calculated such that no single stock has a weightage of more than 33%, and that of top 3 stocks cumulatively shall not be more than 62%.

News

Bharat Electronics revises record date for interim dividend

Bharat Electronics has revised the record date to 06 March 2026 for the purpose of payment of interim div...

Mar 02, 2026 14:07
Tanfac Industries fixes record date for stock split

Tanfac Industries has fixed 09 March 2026 as record date for determining eligibility of equity shareholde...

Feb 28, 2026 11:45
John Cockerill India fixes record date for final dividend

John Cockerill India has fixed 06 March 2026 as record date for payment of final dividend of Rs 7 per equ...

Feb 26, 2026 16:09
KSB fixes record date for final dividend

KSB has fixed 08 May 2025 as record date for payment of final dividend of Rs 4.40 per equity share for FY...

Feb 25, 2026 18:54
SBI Life Insurance Company fixes record date for interim dividend

SBI Life Insurance Company has fixed 06 March 2026 as record date for interim dividend of Rs 2.70 per sha...

Feb 25, 2026 18:46
Naperol Investments fixes record date for interim dividend

Naperol Investments has fixed 04 March 2026 as record date for payment of interim dividend of Rs 3 per eq...

Feb 25, 2026 16:59
Disclaimer

ICICI Securities Ltd. Registered office of ICICI Securities is at ICICI Securities Ltd. - ICICI Venture House, Appasaheb Marathe Marg, Mumbai - 400025, India, Tel No:- 022 - 2288 2460, 022 - 2288 2470. ICICI Securities is a Member of National Stock Exchange of India Ltd (Member Code:-07730) and BSE Ltd (Member Code :103) and having SEBI registration no. INZ000183631. SEBI research analyst Registration no.-INH000000990. Name of the Compliance officer (broking): Mr. Anoop Goyal, Contact number: 022-40701000, E-mail address: complianceofficer@icicisecurities.com. Investment in securities market are subject to market risks, read all the related documents carefully before investing. The contents herein above shall not be considered as an invitation or persuasion to trade or invest.  ICICI Securities and affiliates accept no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon. The non-broking products / services like Mutual Funds, Insurance, FD/ Bonds, loans, PMS, Tax, Elocker, NPS, IPO, Research, Financial Learning etc. are not exchange traded products / services and ICICI Securities Ltd. is just acting as a distributor/ referral Agent of such products / services and all disputes with respect to the distribution activity would not have access to Exchange investor redressal or Arbitration mechanism.